 | • レポートコード：QYR2104Z1830 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、糖尿病性胃不全麻痺治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（運動促進剤、制吐剤、その他）、用途別市場規模（病院薬局、民間クリニック、ドラッグストア、Eコマース）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・糖尿病性胃不全麻痺治療薬の市場動向 ・企業の競争状況、市場シェア ・糖尿病性胃不全麻痺治療薬の種類別市場規模（運動促進剤、制吐剤、その他） ・糖尿病性胃不全麻痺治療薬の用途別市場規模（病院薬局、民間クリニック、ドラッグストア、Eコマース） ・糖尿病性胃不全麻痺治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・糖尿病性胃不全麻痺治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖尿病性胃不全麻痺治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖尿病性胃不全麻痺治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・糖尿病性胃不全麻痺治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sumitomo、Cadila Pharmaceuticals、Sanofi、Teva、Johnson & Johnson、Pfizer、Kyowa Kirin Pharmaceuticals、Hanmi Pharm、Ani Pharmaceuticals） ・結論 |
Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes.
Market Analysis and Insights: Global Diabetic Gastroparesis Drugs Market
The global Diabetic Gastroparesis Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetic Gastroparesis Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetic Gastroparesis Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetic Gastroparesis Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetic Gastroparesis Drugs market.
Global Diabetic Gastroparesis Drugs Scope and Market Size
Diabetic Gastroparesis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Gastroparesis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Prokinetic Agents
Antiemetic Agents
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Drug Stores
E-Commerce
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Gastroparesis Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prokinetic Agents
1.2.3 Antiemetic Agents
1.2.4 Others
1.3 Market by Application
1.3.1 Global Diabetic Gastroparesis Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Drug Stores
1.3.5 E-Commerce
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Gastroparesis Drugs Market Perspective (2016-2027)
2.2 Diabetic Gastroparesis Drugs Growth Trends by Regions
2.2.1 Diabetic Gastroparesis Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetic Gastroparesis Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Diabetic Gastroparesis Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Diabetic Gastroparesis Drugs Industry Dynamic
2.3.1 Diabetic Gastroparesis Drugs Market Trends
2.3.2 Diabetic Gastroparesis Drugs Market Drivers
2.3.3 Diabetic Gastroparesis Drugs Market Challenges
2.3.4 Diabetic Gastroparesis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Gastroparesis Drugs Players by Revenue
3.1.1 Global Top Diabetic Gastroparesis Drugs Players by Revenue (2016-2021)
3.1.2 Global Diabetic Gastroparesis Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Diabetic Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Gastroparesis Drugs Revenue
3.4 Global Diabetic Gastroparesis Drugs Market Concentration Ratio
3.4.1 Global Diabetic Gastroparesis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Gastroparesis Drugs Revenue in 2020
3.5 Diabetic Gastroparesis Drugs Key Players Head office and Area Served
3.6 Key Players Diabetic Gastroparesis Drugs Product Solution and Service
3.7 Date of Enter into Diabetic Gastroparesis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Gastroparesis Drugs Breakdown Data by Type
4.1 Global Diabetic Gastroparesis Drugs Historic Market Size by Type (2016-2021)
4.2 Global Diabetic Gastroparesis Drugs Forecasted Market Size by Type (2022-2027)
5 Diabetic Gastroparesis Drugs Breakdown Data by Application
5.1 Global Diabetic Gastroparesis Drugs Historic Market Size by Application (2016-2021)
5.2 Global Diabetic Gastroparesis Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Diabetic Gastroparesis Drugs Market Size (2016-2027)
6.2 North America Diabetic Gastroparesis Drugs Market Size by Type
6.2.1 North America Diabetic Gastroparesis Drugs Market Size by Type (2016-2021)
6.2.2 North America Diabetic Gastroparesis Drugs Market Size by Type (2022-2027)
6.2.3 North America Diabetic Gastroparesis Drugs Market Size by Type (2016-2027)
6.3 North America Diabetic Gastroparesis Drugs Market Size by Application
6.3.1 North America Diabetic Gastroparesis Drugs Market Size by Application (2016-2021)
6.3.2 North America Diabetic Gastroparesis Drugs Market Size by Application (2022-2027)
6.3.3 North America Diabetic Gastroparesis Drugs Market Size by Application (2016-2027)
6.4 North America Diabetic Gastroparesis Drugs Market Size by Country
6.4.1 North America Diabetic Gastroparesis Drugs Market Size by Country (2016-2021)
6.4.2 North America Diabetic Gastroparesis Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Diabetic Gastroparesis Drugs Market Size (2016-2027)
7.2 Europe Diabetic Gastroparesis Drugs Market Size by Type
7.2.1 Europe Diabetic Gastroparesis Drugs Market Size by Type (2016-2021)
7.2.2 Europe Diabetic Gastroparesis Drugs Market Size by Type (2022-2027)
7.2.3 Europe Diabetic Gastroparesis Drugs Market Size by Type (2016-2027)
7.3 Europe Diabetic Gastroparesis Drugs Market Size by Application
7.3.1 Europe Diabetic Gastroparesis Drugs Market Size by Application (2016-2021)
7.3.2 Europe Diabetic Gastroparesis Drugs Market Size by Application (2022-2027)
7.3.3 Europe Diabetic Gastroparesis Drugs Market Size by Application (2016-2027)
7.4 Europe Diabetic Gastroparesis Drugs Market Size by Country
7.4.1 Europe Diabetic Gastroparesis Drugs Market Size by Country (2016-2021)
7.4.2 Europe Diabetic Gastroparesis Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Diabetic Gastroparesis Drugs Market Size (2016-2027)
8.2 Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Type
8.2.1 Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Application
8.3.1 Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Region
8.4.1 Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetic Gastroparesis Drugs Market Size (2016-2027)
9.2 Latin America Diabetic Gastroparesis Drugs Market Size by Type
9.2.1 Latin America Diabetic Gastroparesis Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Diabetic Gastroparesis Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Diabetic Gastroparesis Drugs Market Size by Type (2016-2027)
9.3 Latin America Diabetic Gastroparesis Drugs Market Size by Application
9.3.1 Latin America Diabetic Gastroparesis Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Diabetic Gastroparesis Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Diabetic Gastroparesis Drugs Market Size by Application (2016-2027)
9.4 Latin America Diabetic Gastroparesis Drugs Market Size by Country
9.4.1 Latin America Diabetic Gastroparesis Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Diabetic Gastroparesis Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetic Gastroparesis Drugs Market Size (2016-2027)
10.2 Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Type
10.2.1 Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Application
10.3.1 Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Country
10.4.1 Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sumitomo
11.1.1 Sumitomo Company Details
11.1.2 Sumitomo Business Overview
11.1.3 Sumitomo Diabetic Gastroparesis Drugs Introduction
11.1.4 Sumitomo Revenue in Diabetic Gastroparesis Drugs Business (2016-2021)
11.1.5 Sumitomo Recent Development
11.2 Cadila Pharmaceuticals
11.2.1 Cadila Pharmaceuticals Company Details
11.2.2 Cadila Pharmaceuticals Business Overview
11.2.3 Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Introduction
11.2.4 Cadila Pharmaceuticals Revenue in Diabetic Gastroparesis Drugs Business (2016-2021)
11.2.5 Cadila Pharmaceuticals Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Diabetic Gastroparesis Drugs Introduction
11.3.4 Sanofi Revenue in Diabetic Gastroparesis Drugs Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Diabetic Gastroparesis Drugs Introduction
11.4.4 Teva Revenue in Diabetic Gastroparesis Drugs Business (2016-2021)
11.4.5 Teva Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Diabetic Gastroparesis Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Diabetic Gastroparesis Drugs Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Diabetic Gastroparesis Drugs Introduction
11.6.4 Pfizer Revenue in Diabetic Gastroparesis Drugs Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Kyowa Kirin Pharmaceuticals
11.7.1 Kyowa Kirin Pharmaceuticals Company Details
11.7.2 Kyowa Kirin Pharmaceuticals Business Overview
11.7.3 Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Introduction
11.7.4 Kyowa Kirin Pharmaceuticals Revenue in Diabetic Gastroparesis Drugs Business (2016-2021)
11.7.5 Kyowa Kirin Pharmaceuticals Recent Development
11.8 Hanmi Pharm
11.8.1 Hanmi Pharm Company Details
11.8.2 Hanmi Pharm Business Overview
11.8.3 Hanmi Pharm Diabetic Gastroparesis Drugs Introduction
11.8.4 Hanmi Pharm Revenue in Diabetic Gastroparesis Drugs Business (2016-2021)
11.8.5 Hanmi Pharm Recent Development
11.9 Ani Pharmaceuticals
11.9.1 Ani Pharmaceuticals Company Details
11.9.2 Ani Pharmaceuticals Business Overview
11.9.3 Ani Pharmaceuticals Diabetic Gastroparesis Drugs Introduction
11.9.4 Ani Pharmaceuticals Revenue in Diabetic Gastroparesis Drugs Business (2016-2021)
11.9.5 Ani Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Diabetic Gastroparesis Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prokinetic Agents
Table 3. Key Players of Antiemetic Agents
Table 4. Key Players of Others
Table 5. Global Diabetic Gastroparesis Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Diabetic Gastroparesis Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Diabetic Gastroparesis Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Diabetic Gastroparesis Drugs Market Share by Regions (2016-2021)
Table 9. Global Diabetic Gastroparesis Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Diabetic Gastroparesis Drugs Market Share by Regions (2022-2027)
Table 11. Diabetic Gastroparesis Drugs Market Trends
Table 12. Diabetic Gastroparesis Drugs Market Drivers
Table 13. Diabetic Gastroparesis Drugs Market Challenges
Table 14. Diabetic Gastroparesis Drugs Market Restraints
Table 15. Global Diabetic Gastroparesis Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Diabetic Gastroparesis Drugs Market Share by Players (2016-2021)
Table 17. Global Top Diabetic Gastroparesis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Gastroparesis Drugs as of 2020)
Table 18. Ranking of Global Top Diabetic Gastroparesis Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Diabetic Gastroparesis Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Diabetic Gastroparesis Drugs Product Solution and Service
Table 22. Date of Enter into Diabetic Gastroparesis Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diabetic Gastroparesis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Diabetic Gastroparesis Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Diabetic Gastroparesis Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Diabetic Gastroparesis Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Diabetic Gastroparesis Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Diabetic Gastroparesis Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Diabetic Gastroparesis Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Diabetic Gastroparesis Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Diabetic Gastroparesis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Diabetic Gastroparesis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Diabetic Gastroparesis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Diabetic Gastroparesis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Diabetic Gastroparesis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Diabetic Gastroparesis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Diabetic Gastroparesis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Diabetic Gastroparesis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Diabetic Gastroparesis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Diabetic Gastroparesis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Diabetic Gastroparesis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Diabetic Gastroparesis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Diabetic Gastroparesis Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Diabetic Gastroparesis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Diabetic Gastroparesis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Diabetic Gastroparesis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Diabetic Gastroparesis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Diabetic Gastroparesis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Diabetic Gastroparesis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Diabetic Gastroparesis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Sumitomo Company Details
Table 63. Sumitomo Business Overview
Table 64. Sumitomo Diabetic Gastroparesis Drugs Product
Table 65. Sumitomo Revenue in Diabetic Gastroparesis Drugs Business (2016-2021) & (US$ Million)
Table 66. Sumitomo Recent Development
Table 67. Cadila Pharmaceuticals Company Details
Table 68. Cadila Pharmaceuticals Business Overview
Table 69. Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Product
Table 70. Cadila Pharmaceuticals Revenue in Diabetic Gastroparesis Drugs Business (2016-2021) & (US$ Million)
Table 71. Cadila Pharmaceuticals Recent Development
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Diabetic Gastroparesis Drugs Product
Table 75. Sanofi Revenue in Diabetic Gastroparesis Drugs Business (2016-2021) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Teva Company Details
Table 78. Teva Business Overview
Table 79. Teva Diabetic Gastroparesis Drugs Product
Table 80. Teva Revenue in Diabetic Gastroparesis Drugs Business (2016-2021) & (US$ Million)
Table 81. Teva Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Diabetic Gastroparesis Drugs Product
Table 85. Johnson & Johnson Revenue in Diabetic Gastroparesis Drugs Business (2016-2021) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Diabetic Gastroparesis Drugs Product
Table 90. Pfizer Revenue in Diabetic Gastroparesis Drugs Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Kyowa Kirin Pharmaceuticals Company Details
Table 93. Kyowa Kirin Pharmaceuticals Business Overview
Table 94. Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Product
Table 95. Kyowa Kirin Pharmaceuticals Revenue in Diabetic Gastroparesis Drugs Business (2016-2021) & (US$ Million)
Table 96. Kyowa Kirin Pharmaceuticals Recent Development
Table 97. Hanmi Pharm Company Details
Table 98. Hanmi Pharm Business Overview
Table 99. Hanmi Pharm Revenue in Diabetic Gastroparesis Drugs Business (2016-2021) & (US$ Million)
Table 100. Hanmi Pharm Recent Development
Table 101. Ani Pharmaceuticals Company Details
Table 102. Ani Pharmaceuticals Business Overview
Table 103. Ani Pharmaceuticals Diabetic Gastroparesis Drugs Product
Table 104. Ani Pharmaceuticals Revenue in Diabetic Gastroparesis Drugs Business (2016-2021) & (US$ Million)
Table 105. Ani Pharmaceuticals Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Gastroparesis Drugs Market Share by Type: 2020 VS 2027
Figure 2. Prokinetic Agents Features
Figure 3. Antiemetic Agents Features
Figure 4. Others Features
Figure 5. Global Diabetic Gastroparesis Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Private Clinics Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. E-Commerce Case Studies
Figure 10. Diabetic Gastroparesis Drugs Report Years Considered
Figure 11. Global Diabetic Gastroparesis Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Diabetic Gastroparesis Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Diabetic Gastroparesis Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Diabetic Gastroparesis Drugs Market Share by Regions (2022-2027)
Figure 15. Global Diabetic Gastroparesis Drugs Market Share by Players in 2020
Figure 16. Global Top Diabetic Gastroparesis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Gastroparesis Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Diabetic Gastroparesis Drugs Revenue in 2020
Figure 18. Global Diabetic Gastroparesis Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Diabetic Gastroparesis Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Diabetic Gastroparesis Drugs Market Share by Type (2016-2027)
Figure 22. North America Diabetic Gastroparesis Drugs Market Share by Application (2016-2027)
Figure 23. North America Diabetic Gastroparesis Drugs Market Share by Country (2016-2027)
Figure 24. United States Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Diabetic Gastroparesis Drugs Market Share by Type (2016-2027)
Figure 28. Europe Diabetic Gastroparesis Drugs Market Share by Application (2016-2027)
Figure 29. Europe Diabetic Gastroparesis Drugs Market Share by Country (2016-2027)
Figure 30. Germany Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Diabetic Gastroparesis Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Diabetic Gastroparesis Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Diabetic Gastroparesis Drugs Market Share by Region (2016-2027)
Figure 40. China Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Diabetic Gastroparesis Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Diabetic Gastroparesis Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Diabetic Gastroparesis Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Diabetic Gastroparesis Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Diabetic Gastroparesis Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Diabetic Gastroparesis Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Diabetic Gastroparesis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Sumitomo Revenue Growth Rate in Diabetic Gastroparesis Drugs Business (2016-2021)
Figure 60. Cadila Pharmaceuticals Revenue Growth Rate in Diabetic Gastroparesis Drugs Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Diabetic Gastroparesis Drugs Business (2016-2021)
Figure 62. Teva Revenue Growth Rate in Diabetic Gastroparesis Drugs Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Diabetic Gastroparesis Drugs Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Diabetic Gastroparesis Drugs Business (2016-2021)
Figure 65. Kyowa Kirin Pharmaceuticals Revenue Growth Rate in Diabetic Gastroparesis Drugs Business (2016-2021)
Figure 66. Hanmi Pharm Revenue Growth Rate in Diabetic Gastroparesis Drugs Business (2016-2021)
Figure 67. Ani Pharmaceuticals Revenue Growth Rate in Diabetic Gastroparesis Drugs Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の糖尿病性胃不全麻痺治療市場規模・現状・予測（2021年-2027年） Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes. During normal digestion, the stomach contracts to help break down food and move it into the small intestine. Gastroparesis disrupts the stomach’s contraction, which can interrupt digestion. Diabetes…- 世界の糖尿病性胃不全麻痺治療市場規模・現状・予測（2021年-2027年） Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes. During normal digestion, the stomach contracts to help break down food and move it into the small intestine. Gastroparesis disrupts the stomach’s contraction, which can interrupt digestion. Diabetes…
- 世界の特発性胃不全用麻痺薬市場規模・現状・予測（2021年-2027年） Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents. Market Analysis and Insights: Global Idiopathic Gastroparesis Drugs Market The global Idiopathic Gastroparesis Drugs market size is proje…
- 世界の糖尿病性胃不全麻痺治療薬市場規模・現状・予測（2021年-2027年） Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes. Market Analysis and Insights: Global Diabetic Gastroparesis Treatment Products Market The global Diabetic Gastroparesis Treatment Products market size is projected to reach US$ XX million by 2027, f…
- 世界の糖尿病網膜症治療薬市場規模・現状・予測（2021年-2027年） Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes. The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising…